Development and alpha-testing of a patient decision aid for patients with chronic myeloid leukemia regarding dose reduction

Abstract Background Dose reduction of tyrosine kinase inhibitors (TKIs) is an option for some chronic myeloid leukemia (CML) patients to minimize side effects while maintaining efficacy. Shared decision-making (SDM) and patient decision aids (PDAs) are advocated to make informed choices such as redu...

Full description

Saved in:
Bibliographic Details
Main Authors: D. N. Lokhorst, M. F. Djodikromo, R. P. M. G. Hermens, N. M. A. Blijlevens, C. L. Bekker
Format: Article
Language:English
Published: BMC 2024-12-01
Series:BMC Medical Informatics and Decision Making
Subjects:
Online Access:https://doi.org/10.1186/s12911-024-02806-7
Tags: Add Tag
No Tags, Be the first to tag this record!